245 related articles for article (PubMed ID: 25656537)
1. A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells.
Buchwald ZS; Yang C; Nellore S; Shashkova EV; Davis JL; Cline A; Ko J; Novack DV; DiPaolo R; Aurora R
J Bone Miner Res; 2015 Aug; 30(8):1508-22. PubMed ID: 25656537
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro.
Buchwald ZS; Kiesel JR; DiPaolo R; Pagadala MS; Aurora R
PLoS One; 2012; 7(6):e38199. PubMed ID: 22701612
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast-induced Foxp3+ CD8 T-cells limit bone loss in mice.
Buchwald ZS; Kiesel JR; Yang C; DiPaolo R; Novack DV; Aurora R
Bone; 2013 Sep; 56(1):163-73. PubMed ID: 23756229
[TBL] [Abstract][Full Text] [Related]
4. Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN-γ To Regulate Bone Resorption.
Shashkova EV; Trivedi J; Cline-Smith AB; Ferris C; Buchwald ZS; Gibbs J; Novack D; Aurora R
J Immunol; 2016 Aug; 197(3):726-35. PubMed ID: 27324129
[TBL] [Abstract][Full Text] [Related]
5. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
Tyagi AM; Mansoori MN; Srivastava K; Khan MP; Kureel J; Dixit M; Shukla P; Trivedi R; Chattopadhyay N; Singh D
J Bone Miner Res; 2014 Sep; 29(9):1981-92. PubMed ID: 24677326
[TBL] [Abstract][Full Text] [Related]
6. A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species.
Hong G; Chen Z; Han X; Zhou L; Pang F; Wu R; Shen Y; He X; Hong Z; Li Z; He W; Wei Q
Clin Transl Med; 2021 May; 11(5):e392. PubMed ID: 34047464
[TBL] [Abstract][Full Text] [Related]
7. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
[TBL] [Abstract][Full Text] [Related]
8. Cajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL-induced signaling pathways.
Sun Y; Liu Y; He W; Wang C; Tickner J; Kuek V; Zhou C; Wang H; Zou X; Hong Z; Yang F; Shao M; Chen L; Xu J
J Cell Physiol; 2019 Jul; 234(7):11792-11804. PubMed ID: 30515822
[TBL] [Abstract][Full Text] [Related]
9. Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease.
Ernst CW; Lee JE; Nakanishi T; Karimbux NY; Rezende TM; Stashenko P; Seki M; Taubman MA; Kawai T
Clin Exp Immunol; 2007 May; 148(2):271-80. PubMed ID: 17355249
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways.
Zhou L; Liu Q; Yang M; Wang T; Yao J; Cheng J; Yuan J; Lin X; Zhao J; Tickner J; Xu J
J Bone Miner Res; 2016 May; 31(5):964-74. PubMed ID: 26684711
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling.
AlQranei MS; Senbanjo LT; Aljohani H; Hamza T; Chellaiah MA
BMC Immunol; 2021 Mar; 22(1):23. PubMed ID: 33765924
[TBL] [Abstract][Full Text] [Related]
12. Cumambrin A prevents OVX-induced osteoporosis
Zhou L; Liu Q; Hong G; Song F; Zhao J; Yuan J; Xu J; Tan RX; Tickner J; Gu Q; Xu J
FASEB J; 2019 Jun; 33(6):6726-6735. PubMed ID: 30807230
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1.
Yamashita T; Yao Z; Li F; Zhang Q; Badell IR; Schwarz EM; Takeshita S; Wagner EF; Noda M; Matsuo K; Xing L; Boyce BF
J Biol Chem; 2007 Jun; 282(25):18245-18253. PubMed ID: 17485464
[TBL] [Abstract][Full Text] [Related]
14. Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.
Cheng J; Zhou L; Liu Q; Tickner J; Tan Z; Li X; Liu M; Lin X; Wang T; Pavlos NJ; Zhao J; Xu J
J Cell Physiol; 2018 Mar; 233(3):2502-2512. PubMed ID: 28771720
[TBL] [Abstract][Full Text] [Related]
15. Onc201 reduces osteoclastogenesis and prevents ovariectomy-induced bone loss via inhibiting RANKL-induced NFATc1 activation and the integrin signaling pathway.
Wu L; Liang J; Li J; Xu Y; Chen J; Su Y; Xian Y; Wei J; Xu J; Zhao J; Liu Q; Yang Y
Eur J Pharmacol; 2022 May; 923():174908. PubMed ID: 35405113
[TBL] [Abstract][Full Text] [Related]
16. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
Chen X; Zhi X; Pan P; Cui J; Cao L; Weng W; Zhou Q; Wang L; Zhai X; Zhao Q; Hu H; Huang B; Su J
FASEB J; 2017 Nov; 31(11):4855-4865. PubMed ID: 28739641
[TBL] [Abstract][Full Text] [Related]
17. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation.
Wu G; Pan L; Sun J; Chen G; Wang S
Menopause; 2019 Jul; 26(7):785-792. PubMed ID: 31083022
[TBL] [Abstract][Full Text] [Related]
19. Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.
Lin X; Yuan G; Yang B; Xie C; Zhou Z; Liu Y; Liu Z; Wu Z; Akimoto Y; Li N; Xu R; Song F
Phytomedicine; 2024 Jul; 129():155559. PubMed ID: 38579642
[TBL] [Abstract][Full Text] [Related]
20. Zanthoxylum piperitum alleviates the bone loss in osteoporosis via inhibition of RANKL-induced c-fos/NFATc1/NF-κB pathway.
Kim MH; Lee H; Ha IJ; Yang WM
Phytomedicine; 2021 Jan; 80():153397. PubMed ID: 33130475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
